Health and Fitness Health and Fitness
Thu, January 19, 2012
[ Thu, Jan 19th 2012 ] - Market Wire
Mortgage Rates Hold Steady

Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012


Published on 2012-01-19 04:14:21 - Market Wire
  Print publication without navigation


Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012 -- MINNEAPOLIS, Jan. 19, 2012 /PRNewswire/ --

Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012

[ ]

MINNEAPOLIS, Jan. 19, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: [ UPI ]) announced today that it will release financial results for the third quarter of fiscal 2012 ended December 31, 2011, at the market close on Thursday, January 26, 2012.  The Company will host a conference call to discuss these results on Thursday, January 26, 2012 at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call.  Individuals wishing to participate in the conference call should dial 877-941-9205. An audio replay will be available for 30 days following the call at 800-406-7325 (domestic) and 303-590-3030 (international), with the passcode 4502445#.

About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions.  Our focus is the continued commercialization of our Urgent PC Neuromodulation System, which we believe is the only FDA-cleared minimally invasive, office-based neuromodulation therapy for the treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency and urge incontinence.

We also offer Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency.  For more information on the company and its products, please visit Uroplasty, Inc. at [ www.uroplasty.com ].

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, Treasurer

952.426.6140

EVC Group

Doug Sherk (Investors), 415.652.9100

Jenifer Kirtland (Investors), 415.568.9349

Chris Gale (Media), 646.201.5431

SOURCE Uroplasty, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.uroplasty.com ]